These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 790835)

  • 21. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 28. Serologic examinations in rheumatology.
    Kitridou RC
    Am Fam Physician; 1972 Mar; 5(3):99-104. PubMed ID: 4558695
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
    Wranicz A
    Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors].
    Peltier AP; Strejcek G
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485
    [No Abstract]   [Full Text] [Related]  

  • 32. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 33. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kinetoplast of Crithidia luciliae as a substrate for demonstrating antibodies against native DNA in systemic lupus erythematosus].
    Herrera-Esparza R; Escobar-Luján M; Avalos-Díaz E; Guzmán-Enríquez L
    Bol Med Hosp Infant Mex; 1983 Apr; 40(4):208-11. PubMed ID: 6347221
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Antibodies to DSDNA in patients with rheumatic disease other than systemic lupus (SLE).
    Bell C; Schur PH
    Arthritis Rheum; 1975; 18(3):284. PubMed ID: 1079729
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of anti-DNA antibodies by electrosyneresis and complement fixation technique in the serum of systemic lupus erythematosus.
    Kusaba T; Kodama T; Hachimine K; Kisu T
    Fukuoka Igaku Zasshi; 1978 Jul; 69(7):319-25. PubMed ID: 308477
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
    Whitehouse IJ; Fehr K; Wagenhäuser FJ
    Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Better characterization of antinuclear factors].
    Stojan B
    Verh Dtsch Ges Rheumatol; 1976; 4():427-32. PubMed ID: 1087085
    [No Abstract]   [Full Text] [Related]  

  • 40. [Arthritis in definitive systemic lupus erythematosus].
    Haberhauer G
    Z Arztl Fortbild (Jena); 1990; 84(3):85-7. PubMed ID: 2343605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.